ANI PHARMACEUTICALS INC. - COMMON STOCK

ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance

08 Nov 2024 06:50:28 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November

04 Nov 2024 16:30:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET

30 Oct 2024 17:00:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%

25 Oct 2024 06:50:54 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024

24 Oct 2024 06:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%

26 Sep 2024 06:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences

16 Sep 2024 08:53:27 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences

16 Sep 2024 06:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution

13 Sep 2024 06:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger

11 Sep 2024 06:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences

10 Sep 2024 14:09:55 By Nasdaq GlobeNewswire

ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers’ Option to Purchase Additional Notes

13 Aug 2024 16:05:27 By Nasdaq GlobeNewswire

ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering

07 Aug 2024 21:44:18 By Nasdaq GlobeNewswire

ANI Pharmaceuticals, Inc. Announces Proposed Convertible Senior Notes Offering

07 Aug 2024 07:00:55 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Reports Second Quarter 2024 Financial Results and Raises 2024 Guidance

06 Aug 2024 06:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Discuss Second Quarter 2024 Financial Results on August 6, 2024, at 8:30 a.m. ET

31 Jul 2024 07:00:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder

15 Jul 2024 07:00:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP

02 Jul 2024 07:00:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals’ CEO Nikhil Lalwani Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner

25 Jun 2024 07:00:02 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences

24 Jun 2024 06:50:44 By Nasdaq GlobeNewswire